Cargando…

Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p

BACKGROUND: Emerging evidence has revealed that circular RNAs (circRNAs) participated in hepatocellular carcinoma (HCC) development. However, the roles of most circRNAs have not been studied. METHODS: CircZNF609, miR-342-3p and RAP2C expressions were assessed by qPCR or Western blot. Loss-of-functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xin, Zhan, Wei, Tian, Bin, Luo, Yilin, Gu, Fang, Li, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414977/
https://www.ncbi.nlm.nih.gov/pubmed/32801783
http://dx.doi.org/10.2147/OTT.S253936
_version_ 1783569078355492864
author Liao, Xin
Zhan, Wei
Tian, Bin
Luo, Yilin
Gu, Fang
Li, Rui
author_facet Liao, Xin
Zhan, Wei
Tian, Bin
Luo, Yilin
Gu, Fang
Li, Rui
author_sort Liao, Xin
collection PubMed
description BACKGROUND: Emerging evidence has revealed that circular RNAs (circRNAs) participated in hepatocellular carcinoma (HCC) development. However, the roles of most circRNAs have not been studied. METHODS: CircZNF609, miR-342-3p and RAP2C expressions were assessed by qPCR or Western blot. Loss-of-function experiments were performed using si-circZNF609 transfection, followed by CCK-8 assay, flow cytometry, wound healing assay and transwell assay. Informatic tools and rescue experiments were carried out to investigate the underlying mechanisms. RESULTS: We showed that circZNF609 was overexpressed in HCC tissues and cells, as well as associated with poor clinical characteristics. Depletion of circZNF609 restrained HCC cell viability, migration and invasion while enhanced cell apoptosis. As to mechanism, miR-342-3p was sponged by circZNF609, and RAP2C was targeted by miR-342-3p. The effects on HCC cells induced by si-circZNF609 could be reversed by miR-342-3p inhibitor or RAP2C. In vivo, circZNF609 knockdown inhibited tumorigenesis of HCC mice, confirming the findings in vitro. CONCLUSION: CircZNF609 was highly expressed in HCC tissues and driven HCC progression by sponging miR-342-3p and upregulating RAP2C. This study may provide new potential therapeutic targets for HCC treatment.
format Online
Article
Text
id pubmed-7414977
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-74149772020-08-14 Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p Liao, Xin Zhan, Wei Tian, Bin Luo, Yilin Gu, Fang Li, Rui Onco Targets Ther Original Research BACKGROUND: Emerging evidence has revealed that circular RNAs (circRNAs) participated in hepatocellular carcinoma (HCC) development. However, the roles of most circRNAs have not been studied. METHODS: CircZNF609, miR-342-3p and RAP2C expressions were assessed by qPCR or Western blot. Loss-of-function experiments were performed using si-circZNF609 transfection, followed by CCK-8 assay, flow cytometry, wound healing assay and transwell assay. Informatic tools and rescue experiments were carried out to investigate the underlying mechanisms. RESULTS: We showed that circZNF609 was overexpressed in HCC tissues and cells, as well as associated with poor clinical characteristics. Depletion of circZNF609 restrained HCC cell viability, migration and invasion while enhanced cell apoptosis. As to mechanism, miR-342-3p was sponged by circZNF609, and RAP2C was targeted by miR-342-3p. The effects on HCC cells induced by si-circZNF609 could be reversed by miR-342-3p inhibitor or RAP2C. In vivo, circZNF609 knockdown inhibited tumorigenesis of HCC mice, confirming the findings in vitro. CONCLUSION: CircZNF609 was highly expressed in HCC tissues and driven HCC progression by sponging miR-342-3p and upregulating RAP2C. This study may provide new potential therapeutic targets for HCC treatment. Dove 2020-08-04 /pmc/articles/PMC7414977/ /pubmed/32801783 http://dx.doi.org/10.2147/OTT.S253936 Text en © 2020 Liao et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liao, Xin
Zhan, Wei
Tian, Bin
Luo, Yilin
Gu, Fang
Li, Rui
Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p
title Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p
title_full Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p
title_fullStr Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p
title_full_unstemmed Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p
title_short Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p
title_sort circular rna znf609 promoted hepatocellular carcinoma progression by upregulating pap2c expression via sponging mir-342-3p
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414977/
https://www.ncbi.nlm.nih.gov/pubmed/32801783
http://dx.doi.org/10.2147/OTT.S253936
work_keys_str_mv AT liaoxin circularrnaznf609promotedhepatocellularcarcinomaprogressionbyupregulatingpap2cexpressionviaspongingmir3423p
AT zhanwei circularrnaznf609promotedhepatocellularcarcinomaprogressionbyupregulatingpap2cexpressionviaspongingmir3423p
AT tianbin circularrnaznf609promotedhepatocellularcarcinomaprogressionbyupregulatingpap2cexpressionviaspongingmir3423p
AT luoyilin circularrnaznf609promotedhepatocellularcarcinomaprogressionbyupregulatingpap2cexpressionviaspongingmir3423p
AT gufang circularrnaznf609promotedhepatocellularcarcinomaprogressionbyupregulatingpap2cexpressionviaspongingmir3423p
AT lirui circularrnaznf609promotedhepatocellularcarcinomaprogressionbyupregulatingpap2cexpressionviaspongingmir3423p